# ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation

> **NCT05021835** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Novo Nordisk A/S** · enrollment: 6200 (estimated)

## Conditions studied

- Cardiovascular Risk
- Chronic Kidney Disease
- Inflammation

## Interventions

- **DRUG:** Ziltivekimab B
- **DRUG:** Ziltivekimab C
- **DRUG:** Placebo (Ziltivekimab B)
- **DRUG:** Placebo (Ziltivekimab C)

## Key facts

- **NCT ID:** NCT05021835
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-08-30
- **Primary completion:** 2026-06-09
- **Final completion:** 2026-06-09
- **Target enrollment:** 6200 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05021835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05021835, "ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05021835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*